Supplementary key words arachidonic acid • endothelial cells • cyclooxygenase 2 • mass spectrometry • cancer • metabolism • soluble epoxide hydrolase • angiogenesis Epoxyeicosatrienoic acids (EETs) are biologically active omega-6 fatty acids generated through the cytochrome P450 (CYP) oxidation of arachidonic acid (ARA). Endothelial cells express endogenous levels of CYP2B, CYP2C, and CYP2J subfamilies, which form four EET regioisomers (5,8,11,and 14, (1, 2). EETs can also be formed by other CYPs, particularly when they are induced (3). The EETs act in part to change the membrane potential and tone of the vascular wall; they are strong vasodilators that lead to reduced blood pressure (4, 5) and are endothelium-derived hyperpolarizing factors that activate Ca 2+ -activated K + channels in vascular smooth muscle cells and coronary arteries (6, 7). EETs also act as secondary messengers in numerous signal-transduction pathways involved in inflammation (8), pain (9), bone growth (10), cell migration (11), apoptosis (12), platelet aggregation (13), and hypoxia/reoxygenation injury (14). Multiple studies have also demonstrated that EETs stimulate endothelial cell proliferation and angiogenesis (1,(15)(16)(17)(18)(19)(20)(21)(22)(23).Angiogenesis is a tightly regulated physiological process that provides oxygen during tissue repair and growth but is also central to the growth and spread of tumors. EETs, Abstract Epoxyeicosatrienoic acids (EETs) are formed from the metabolism of arachidonic acid by cytochrome P450s. EETs promote angiogenesis linked to tumor growth in various cancer models that is attenuated in vivo by cyclooxygenase 2 (COX-2) inhibitors. This study further defines a role for COX-2 in mediating endothelial EET metabolism promoting angiogenesis. Using human aortic endothelial cells (HAECs), we quantified 8,9-EET-induced tube formation and cell migration as indicators of angiogenic potential in the presence and absence of a COX-2 inducer [phorbol 12,13-dibutyrate (PDBu)]. The angiogenic response to 8,9-EET in the presence of PDBu was 3-fold that elicited by 8,9-EET stabilized with a soluble epoxide hydrolase inhibitor (t-TUCB). Contributing to this response was the COX-2 metabolite of 8,9-EET, the 11-hydroxy-8,9-EET (8,9,11-EHET), which exogenously enhanced angiogenic responses in HAECs at levels comparable to those elicited by vascular endothelial growth factor (VEGF). In contrast, the 15-hydroxy-8,9-EET isomer was also formed but inactive. The 8,9,11-EHET also promoted expression of the VEGF family of tyrosine kinase receptors. These results indicate that 8,9-EET-stimulated angiogenesis is enhanced by COX-2 metabolism in the endothelium through the formation of 8,9,11-EHET. This alternative pathway for the metabolism of 8,9-EET may be particularly important in regulating angiogenesis under circumstances in which COX-2 is induced, such as in cancer tumor growth and inflammation.-Rand, A. A